Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Ovary (Late Stage^), 2014-2018

All Races (includes Hispanic), Female, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank ascending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 7.7 (7.6, 7.7) N/A 15,434 73.1
Mississippi 6 *** 6.3 (5.8, 6.9) 50 (36, 50) 118 71.9
South Carolina 6 *** 6.3 (5.9, 6.7) 49 (39, 50) 209 71.7
Maine 6 *** 6.3 (5.6, 7.1) 48 (25, 50) 61 72.9
Alaska 6 *** 6.6 (5.4, 7.9) 47 (4, 50) 23 72.2
Louisiana 3 *** 6.6 (6.2, 7.1) 46 (30, 50) 190 74.4
Nebraska 6 *** 6.7 (6.0, 7.5) 45 (17, 50) 75 69.6
Rhode Island 6 *** 6.8 (5.9, 7.7) 44 (13, 50) 49 72.1
Missouri 6 *** 6.8 (6.4, 7.2) 43 (27, 50) 265 71.8
Delaware 6 *** 6.9 (6.0, 7.9) 42 (9, 50) 46 72.4
Tennessee 6 *** 7.0 (6.6, 7.3) 41 (24, 48) 298 69.3
Kentucky 3 *** 7.0 (6.5, 7.5) 40 (21, 49) 194 74.1
Virginia 6 *** 7.0 (6.7, 7.4) 39 (23, 47) 367 72.8
Arizona 6 *** 7.1 (6.7, 7.5) 38 (21, 47) 308 70.4
Nevada 6 *** 7.1 (6.5, 7.8) 37 (13, 50) 97 68.5
Minnesota 6 *** 7.2 (6.8, 7.6) 36 (19, 47) 244 71.9
Hawaii 3 *** 7.2 (6.4, 8.1) 35 (5, 50) 62 74.9
Texas 6 *** 7.2 (7.0, 7.4) 34 (23, 42) 1,065 67.8
North Carolina 6 *** 7.3 (7.0, 7.6) 33 (19, 44) 468 73.2
North Dakota 6 *** 7.3 (6.2, 8.6) 32 (1, 50) 31 77.7
Alabama 6 *** 7.3 (6.9, 7.7) 31 (15, 46) 234 69.1
Michigan 5 *** 7.3 (7.0, 7.6) 30 (18, 43) 475 72.7
Maryland 6 *** 7.3 (6.9, 7.7) 29 (16, 45) 284 70.1
Ohio 6 *** 7.4 (7.1, 7.6) 28 (18, 42) 567 72.8
Colorado 6 *** 7.5 (7.1, 7.9) 27 (12, 43) 232 73.5
Vermont 6 *** 7.5 (6.3, 8.8) 26 (1, 50) 33 76.0
New Hampshire 6 *** 7.5 (6.7, 8.4) 25 (2, 48) 73 76.9
Iowa 3 *** 7.6 (7.1, 8.2) 24 (6, 44) 156 78.0
Kansas 6 *** 7.6 (7.0, 8.3) 23 (5, 44) 134 74.7
Oklahoma 6 *** 7.7 (7.2, 8.2) 22 (5, 40) 183 71.5
Florida 6 *** 7.8 (7.5, 8.0) 21 (12, 29) 1,145 71.1
Montana 6 *** 7.8 (6.8, 8.9) 20 (1, 48) 53 72.5
Arkansas 6 *** 7.8 (7.2, 8.4) 19 (3, 41) 148 72.8
Indiana 6 *** 7.8 (7.4, 8.2) 18 (7, 34) 323 78.0
New Mexico 3 *** 7.8 (7.2, 8.6) 17 (1, 43) 103 72.2
Illinois 6 *** 7.9 (7.6, 8.2) 16 (9, 29) 624 73.0
Wyoming 6 *** 7.9 (6.6, 9.4) 15 (1, 50) 27 75.8
Connecticut 3 *** 7.9 (7.4, 8.5) 14 (2, 35) 196 79.4
Washington 5 *** 8.1 (7.8, 8.5) 13 (2, 25) 358 76.3
Wisconsin 6 *** 8.2 (7.7, 8.6) 12 (2, 26) 306 75.2
California 3 *** 8.3 (8.1, 8.4) 11 (3, 17) 1,850 75.1
Georgia 3 *** 8.3 (8.0, 8.6) 10 (2, 21) 497 79.7
South Dakota 6 *** 8.4 (7.3, 9.6) 9 (1, 45) 45 80.1
New York 3 *** 8.4 (8.2, 8.7) 8 (1, 15) 1,072 73.7
Idaho 3 *** 8.4 (7.6, 9.3) 7 (1, 35) 83 77.3
Utah 3 *** 8.5 (7.8, 9.2) 6 (1, 29) 117 78.0
Pennsylvania 6 *** 8.5 (8.2, 8.8) 5 (1, 15) 748 74.5
West Virginia 6 *** 8.5 (7.8, 9.3) 4 (1, 29) 111 73.5
Oregon 6 *** 8.5 (8.0, 9.1) 3 (1, 21) 227 75.9
New Jersey 3 *** 8.6 (8.2, 8.9) 2 (1, 16) 505 73.2
District of Columbia 6 *** 9.0 (7.7, 10.6) 1 (1, 41) 32 72.6
Massachusetts 3 ***
data not available
N/A
data not available
data not available
Puerto Rico 6 *** 4.1 (3.8, 4.5) N/A 98 54.9
Notes:
Created by statecancerprofiles.cancer.gov on 09/26/2022 5:23 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Massachusetts, Puerto Rico

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top